miRNA-containing MV released from activated platelets can enter endothelial cells and regulate ICAM1 expression by blocking NF-κB and the MAPK pathways, thus platelet MV plays a major role in inflammation and atherosclerosis (Gidlöf et al., 2013). This evidence concerns the gene NFKB1 and atherosclerosis.